Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001731122-25-000611
Filing Date
2025-04-25
Accepted
2025-04-25 16:40:36
Documents
1
Period of Report
2024-09-30
Effectiveness Date
2025-04-25

Document Format Files

Seq Description Document Type Size
1 ARS e6533_ars.pdf ARS 1939061
  Complete submission text file 0001731122-25-000611.txt   2653443
Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
Type: ARS | Act: 34 | File No.: 001-37606 | Film No.: 25874807
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)